ZEISS Vision Care has bought a suite of patents from Japanese chemical company Mitsui Chemicals (MCI) saying the strategic purchase will open “new opportunities for the development of electro-active lenses and spectacle frames”.
“An innovative area for eye care will be the combination of electrically controlled functions with lenses and spectacles. The acquired IP (intellectual property) portfolio acquired from MCI comprises a range of ground-breaking patents that encompass various electric functionalities tailored for eyeglass lenses and frame electronics,” ZEISS Vision Care said in a news release.
“This strategic investment aligns seamlessly with ZEISS’ mission to enhance user experience and push the boundaries of technological innovation within the eyewear sector.
“Modern eyeglass lenses can do much more for the eye than just correct visual defects. They can protect the eyes from harmful UV radiation, reduce perceived glare when driving, or reduce digital eye strain when working with computer screens,” the ZEISS statement said.
“This strategic investment aligns seamlessly with ZEISS’ mission… push the boundaries of technological innovation within the eyewear sector.”